These findings mechanistically extend earlier observations that PD-L1 can act as a direct defense against cancer cells and reveal that disruption of PD-L1 expression or antibody-mediated PD-L1 blocking can make cancer cells sensitive to IFN cytotoxicity [59]. This evidence concerns the gene CD274 and cancer.